Chair of pharma firm Roche advocates mandatory Covid-19 vaccination
Christoph Franz said he was in favour of compulsory jabs if vaccination coverage rates were insufficient and if there was a social consensus on the issue.
This content was published on
2 minutes
Keystone-SDA/ac
Português
pt
Presidente de gigante farmacêutica defende vacinação obrigatória
“Solidarity is needed to overcome this crisis together,” Franz said in an interview with the Frankfurter Allgemeine Zeitung. He added that several vaccines had been developed and approved in less than a year. “That normally takes more than five years.”
The 60-year-old wanted production capacities to be built up first. “I am confident that the problems in logistics and distribution of the vaccines will be solved in the next few months,” he told the paper.
The chairman of the Swiss pharma giant was also critical of the focus on prices of vaccines by some countries. He warned that action must be taken more quickly in a pandemic because the damage to the economy is many times greater than cost savings from reducing the price of a vaccine dose.
Roche’s own pill against Covid-19 is still in the second phase of clinical development, Franz said, and has been tested in humans for efficacy and side effects. “We don’t have results yet, but we expect initial data in the next few months and hopefully results from pivotal trials this year.”
On Tuesday, the Swiss government approved the use of Regeneron’s RegN-Cov 2 drug to treat Covid-19 produced by Roche and ordered 3,000 doses of the monoclonal antibody Casirivimab/Imdevimab. The value of the contract is confidential.
Franz has been a board member of Roche since 2011 and chairman since 2014. His profile on the Roche website makes reference to his tendency to say what he thinks.
“He is an unconventional thinker who is not afraid to ask questions that (as he himself says) could turn out to be stupid.”
More
Archived
What do you think of a Covid-19 “vaccine passport” being required for activities such as travelling and going to bars and restaurants?
What do you see as the limits or benefits of this solution?
University students in Switzerland join Gaza protest wave
This content was published on
Pro-Palestinian activists occupied university buildings in Lausanne, Geneva and Zurich on Tuesday, widening the protest movement in the Alpine nation.
TradeXBank to resume full operations after Sberbank Switzerland taken off sanctions list
This content was published on
TradeXBank, the former Swiss branch of Russia’s Sberbank, will be able to resume its dollar-denominated activities from the second half of this year.
Geneva decides not to remove controversial memorials
This content was published on
The city of Geneva has presented an action plan regarding a series of controversial local statues and monuments of historical figures linked to racism, colonialism or slavery.
University of Lausanne calls for end to pro-Palestine sit-in
This content was published on
The pro-Palestinian occupation continues at the University of Lausanne (UNIL). On Monday evening, a group of students refused to agree to the deadline set by the rectorate.
Ukraine peace conference should include Russia, says Chinese ambassador
This content was published on
China supports a peace conference on the Ukraine war that would see equal participation of all parties, says Chinese Ambassador to Russia Zhang Hanhui.
This content was published on
A majority of Swiss citizens have open attitudes towards various infertility treatments, including even egg donation, which is currently prohibited.
Reports of Swiss cyber fraud almost doubled in six months
This content was published on
The head of the new Federal Office for Cybersecurity (FOC), Florian Schütz, has presented a new strategy after just over four months in office.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Switzerland in race for sufficient Covid immunisation
This content was published on
Health authorities have called for an extra effort from the Swiss population to keep Covid infections as low as possible in the next few months.
This content was published on
With its big bet on data and digitilisation, Roche has its eye on a new crop of specialists. Now it just needs to woo them.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.